Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Acetaminophen Safe After Heart Attack

By HospiMedica staff writers
Posted on 02 Jun 2006
A new study in animals finds that acetaminophen is safe to use as a pain reliever and fever reducer after a heart attack, but it does not protect the heart muscle. More...


Researchers at the University of Pennsylvania (Philadelphia, USA) conducted a study to examine the safety of acetaminophen--a popular over-the-counter pain medication under the brand name Tylenol--to relieve pain or reduce fever in people who have had heart attacks, and to determine if acetaminophen could be used in conjunction with reperfusion therapy to salvage heart muscle cells damaged by the heart attack and improve the heart's ventricular function.

The researchers assigned eight sheep and 11 rabbits to a group that received acetaminophen and an equal number of sheep and rabbits to a control group that did not receive any drug. The researchers surgically induced the heart attack and then restored blood flow.

The study found that acetaminophen had no effect on the amount of blood flow to the heart muscle nor on how much heart muscle was saved, and also had no effect on blood pressure, ventricular function, or heart rate. The results are at odds with a previous study using dogs, which concluded that acetaminophen reduced the area affected by a heart attack by 22%. The study was published in the June 2006 issue of the American Journal of Physiology-Heart and Circulatory Physiology.

Some studies have suggested there is an increased risk of stroke and heart attack among patients taking non-steroidal anti-inflammatory drugs (NSAIDs), and a recent clinical study from Denmark suggested that NSAIDs may increase mortality if taken after a heart attack. In search of a substitute, Dr. Robert C. Gorman, an associate professor of surgery at the University of Pennsylvania, and colleagues found that acetaminophen is a safe alternative to NSAIDs after a heart attack.



Related Links:
University of Pennsylvania

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.